Immunogenicity and safety of Quadrivalent Influenza HA vaccine in Indonesian children: An open-labeled, bridging, clinical study
Open Access
- 1 January 2020
- Vol. 38 (5) , 993-1000
Abstract
No abstract availableKeywords
Funding Information
- PT Bio Farma (PO-00017403, 04310/DIR/XI/2017)
This publication has 19 references indexed in Scilit:
- InfluenzaThe Lancet, 2017
- Multiple Viral Infection Detected from Influenza-Like Illness Cases in IndonesiaBioMed Research International, 2017
- A review of the changes to the licensing of influenza vaccines in EuropeInfluenza and Other Respiratory Viruses, 2015
- Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine in US Children 6–35 Months of Age During 2013–2014: Results From A Phase II Randomized TrialJournal of the Pediatric Infectious Diseases Society, 2015
- Safety, immunogenicity, and lot-to-lot consistency of a quadrivalent inactivated influenza vaccine in children, adolescents, and adults: A randomized, controlled, phase III trialVaccine, 2015
- The Burden of Influenza B: A Structured Literature ReviewAmerican Journal of Public Health, 2013
- Surveillance of Influenza in Indonesia, 2003-2007Influenza and Other Respiratory Viruses, 2012
- Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysisThe Lancet, 2011
- Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trialsVaccine, 2009
- Vaccines for preventing influenza in healthy childrenEvidence-Based Child Health: A Cochrane Review Journal, 2006